Targeting Skeletal MTORC1 As A Novel Approach For The Treatment Of Diet-induced Insulin Resistance
Funder
National Health and Medical Research Council
Funding Amount
$586,979.00
Summary
Diet-induced insulin resistance is a pathology that underlies type 2 diabetes. Elucidating the pathways and tissues that contribute to this condition is crucial for drug development. The skeleton has emerged as a critical insulin target tissue. We provide evidence that suppression of mTORC1, a complex over-activated by nutrients, in bone cells improves insulin sensitivity. In this study, we will determine if blocking mTORC1 function in bone cells can treat diet-induced insulin resistance.
A Novel Portable System For Day And Night Closed Loop Automated Insulin Delivery In The Patient With Type 1 Diabetes
Funder
National Health and Medical Research Council
Funding Amount
$251,133.00
Summary
For patients with Type 1 Diabetes, improved glucose control has been shown to reduce the development of diabetes complications. Although advances have been made in therapy, most people with diabetes do not achieve optimal treatment targets and the burden of care is high. Technologies now exist that allow the development of automatic insulin therapy and the artificial pancreas. These experiments will test a novel portable system that represents a significant step advancing toward this goal.
Epilepsy is often poorly controlled by medication and dietary measures can be taken that reduce occurrence of epileptic seizures. Glucose control is impacted by diet and also mutations in the genes that move glucose around the body are known to cause epilepsy. Here we will be studying how the genetic and dietary control of glucose levels impacts brain function to increase seizures and to potentially reveal novel therapies.
Carnitine Acetyltransferase (CrAT) Regulates Appetite And Body Weight Through The Melanocortin System
Funder
National Health and Medical Research Council
Funding Amount
$547,087.00
Summary
Carnitine metabolism in peripheral tissues, such as muscle, maintains appropriate cellular metabolism and function. Little is known about carnitine metabolism in specific populations of brain cells regulate food intake and appetite. This project aims to understand how carnitine metabolism affect brain cells that regulate food intake and body weight.
Glycaemia-increasing Effects Of Sprinting In Type 1 Diabetes: Toward The Validation Of New Clinical Guidelines For Hypoglycaemia Prevention
Funder
National Health and Medical Research Council
Funding Amount
$600,323.00
Summary
Recently, we found that the risk of hypoglycaemia associated with moderate intensity exercise in type 1 diabetic individuals is opposed by one or several short sprints performed during or after exercise. Our goal is to examine if exercising several hours before sprinting decreases its protective effect, and whether sprinting may impair several hours later the counterregulatory responses to hypoglycaemia. Finally, we will determine if guidelines advocating the use of short sprints reduce the risk ....Recently, we found that the risk of hypoglycaemia associated with moderate intensity exercise in type 1 diabetic individuals is opposed by one or several short sprints performed during or after exercise. Our goal is to examine if exercising several hours before sprinting decreases its protective effect, and whether sprinting may impair several hours later the counterregulatory responses to hypoglycaemia. Finally, we will determine if guidelines advocating the use of short sprints reduce the risk of hypoglycaemia under free living conditions.Read moreRead less
Type 2 diabetes is a health crisis in Australia. In this project, we will investigate the mechanisms whereby high glucose and fat impair pancreatic beta-cell function leading to type 2 diabetes. We will establish how endoplasmic reticulum stress and the protein Id1 are linked with loss of beta-cell gene expression and function. The information gained will further our understanding of the basic mechanisms regulating insulin secretion and provide new therapeutic targets for diabetes treatment.
Post-stroke Hyperglycaemia – Treatment With Exenatide In Acute Ischaemic Stroke (TEXAIS) Trial
Funder
National Health and Medical Research Council
Funding Amount
$1,266,149.00
Summary
Raised blood glucose levels (hyperglycaemia) after a stroke is common. It reduces the efficacy of stroke treatments and results in worse outcomes. Insulin is not useful as a treatment for this as it causes frequent hypoglycaemia and does not improve clinical outcomes. Exenatide is a common diabetes drug that is simple to use and lowers blood glucose without hypoglycaemia. It will be tested in the Treatment with Exenatide in Acute Ischaemic Stroke (TEXAIS) trial.
Carnitine Palmitoyl Transferase 1 In POMC Neurons Controls Glucose Homeostasis And Body Weight
Funder
National Health and Medical Research Council
Funding Amount
$474,499.00
Summary
The brain plays a critical role in body weight gain by balancing appetite-inducing and appetite-suppressing signals. An imbalance in this process causes obesity, promotes diabetes and cardiovascular disease. The aim of this research is to identify how appetite-suppressing brain signals are maintained as a method to prevent obesity progression.
Effect Of Bisphosphonates On Bone Architecture And Glucose Metabolism In Men With Prostate Cancer Receiving Androgen Deprivation Therapy: A Randomised Controlled Trial
Funder
National Health and Medical Research Council
Funding Amount
$566,215.00
Summary
Androgen deprivation therapy (ADT) is a type of hormonal treatment which is effective for prostate cancer treatment. However, ADT may cause bone fragility, weight gain, diabetes and heart disease. We will examine the effects of a bone strengthening treatment on bone structure and glucose metabolism in men receiving ADT. This trial should help in better define the risk benefit ratio of ADT, and therefore provide treating doctors with better guidance as to when and how to use this therapy.
Radiosensitisation Of Diffuse Intrinsic Pontine Gliomas By Modulating Glucose Metabolism
Funder
National Health and Medical Research Council
Funding Amount
$325,000.00
Summary
Diffuse intrinsic pontine glioma (DIPG) represents the most aggressive cancer of childhood with no effective treatment available and radiotherapy is the only form of treatment that offers a transient benefit. We have successfully grown the first DIPG cells in the laboratory and found a new approach to radiosensitise them by targeting glucose metabolism. We will build on these findings and develop this treatment strategy to make this novel therapy available to children with this deadly disease.